These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy. Du H; Levine M; Ganesa C; Witte DP; Cole ES; Grabowski GA Am J Hum Genet; 2005 Dec; 77(6):1061-74. PubMed ID: 16380916 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone-mediated up-regulation of the mannose receptor improves the delivery of recombinant glucocerebrosidase to Gaucher macrophages. Zhu Y; Li X; Schuchman EH; Desnick RJ; Cheng SH J Pharmacol Exp Ther; 2004 Feb; 308(2):705-11. PubMed ID: 14610228 [TBL] [Abstract][Full Text] [Related]
5. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments. Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306 [TBL] [Abstract][Full Text] [Related]
6. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders. Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793 [TBL] [Abstract][Full Text] [Related]
7. Imaging of enzyme replacement therapy using PET. Phenix CP; Rempel BP; Colobong K; Doudet DJ; Adam MJ; Clarke LA; Withers SG Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10842-7. PubMed ID: 20534487 [TBL] [Abstract][Full Text] [Related]
8. Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. Van Patten SM; Hughes H; Huff MR; Piepenhagen PA; Waire J; Qiu H; Ganesa C; Reczek D; Ward PV; Kutzko JP; Edmunds T Glycobiology; 2007 May; 17(5):467-78. PubMed ID: 17251309 [TBL] [Abstract][Full Text] [Related]
10. Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages. De Vlaeminck Y; Lecocq Q; Giron P; Heirman C; Geeraerts X; Bolli E; Movahedi K; Massa S; Schoonooghe S; Thielemans K; Goyvaerts C; Van Ginderachter JA; Breckpot K J Control Release; 2019 Apr; 299():107-120. PubMed ID: 30797866 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease. McVie-Wylie AJ; Lee KL; Qiu H; Jin X; Do H; Gotschall R; Thurberg BL; Rogers C; Raben N; O'Callaghan M; Canfield W; Andrews L; McPherson JM; Mattaliano RJ Mol Genet Metab; 2008 Aug; 94(4):448-455. PubMed ID: 18538603 [TBL] [Abstract][Full Text] [Related]
12. SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis. Put S; Schoonooghe S; Devoogdt N; Schurgers E; Avau A; Mitera T; D'Huyvetter M; De Baetselier P; Raes G; Lahoutte T; Matthys P J Nucl Med; 2013 May; 54(5):807-14. PubMed ID: 23447654 [TBL] [Abstract][Full Text] [Related]
13. Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis. Bonten EJ; Wang D; Toy JN; Mann L; Mignardot A; Yogalingam G; D'Azzo A FASEB J; 2004 Jun; 18(9):971-3. PubMed ID: 15084520 [TBL] [Abstract][Full Text] [Related]
14. The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders. Wyatt K; Henley W; Anderson L; Anderson R; Nikolaou V; Stein K; Klinger L; Hughes D; Waldek S; Lachmann R; Mehta A; Vellodi A; Logan S Health Technol Assess; 2012; 16(39):1-543. PubMed ID: 23089251 [TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease. Yi H; Sun T; Armstrong D; Borneman S; Yang C; Austin S; Kishnani PS; Sun B J Mol Med (Berl); 2017 May; 95(5):513-521. PubMed ID: 28154884 [TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells. Bijsterbosch MK; Donker W; van de Bilt H; van Weely S; van Berkel TJ; Aerts JM Eur J Biochem; 1996 Apr; 237(2):344-9. PubMed ID: 8647071 [TBL] [Abstract][Full Text] [Related]
20. Lactosylceramide in lysosomal storage disorders: a comparative immunohistochemical and biochemical study. Hůlková H; Ledvinová J; Asfaw B; Koubek K; Kopriva K; Elleder M Virchows Arch; 2005 Jul; 447(1):31-44. PubMed ID: 15918012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]